A young woman shares her emotional 15-year journey with hidradenitis suppurativa, chronic skin inflammation for which ...

Start with a non-foaming, pH-balanced cleanser to remove overnight oil build-up without stripping ... Step 3: Isotretinoin (Roaccutane) Reserved for severe or cystic acne that has not responded to ...

All products featured on Glamour are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Skin care acids ...

Acne is the most widespread skin disease, affecting more than 231 million people worldwide, according to the Global Burden of Disease study. Some three-quarters of all adolescents and many adults ...

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.

This article is part of Nature Outlook: Skin, an editorially independent supplement produced with financial support from LEO Pharma. About this content. Acne has long been dismissed as an unfortunate ...

Acne has long been dismissed as an unfortunate cosmetic issue — a rite of passage that is ultimately of little importance. But that attitude is changing. Many scientists now accept that acne is an ...

Comedones are a type of acne that occurs when hair follicles in the skin become clogged by oil, dead skin cells, and debris. This causes small bumps commonly known as blackheads (open comedones) or ...

1 Institute of Dermatology, Guangzhou Medical University, Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, China 2 Department of Dermatology, Guangzhou Twelfth People’s Hospital, ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...